CTRZX Fees and Costs — Multi-Manager Total Return Bond Strategies Fund, Institutional Class
Data updated: 2026-07-29
The net expense ratio is 0.48%: a 0.44% management fee plus 0.04% other expenses. There are no sales loads or redemption fees. Portfolio turnover was 225%.
CTRZX Fees and Expenses
Annual operating expenses and sales charges of CTRZX. Prospectus, as of August 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.44% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.04% |
| Gross expense ratio | 0.48% |
| Fee waiver | — |
| Net expense ratio | 0.48% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
CTRZX Costs Over Time
On $10,000 invested in CTRZX, assuming 5% a year before costs, total costs come to $303 over 5 years, cutting the return by 0.50% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.48%) | $50 | $158 | $276 |
| Lost growth on money paid in costs | $0 | $8 | $28 |
| Total costs | $50 | $166 | $303 |
| Value after costs | $10,450 | $11,410 | $12,459 |
| Impact on return, per year | 0.50% | 0.50% | 0.50% |
CTRZX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): $57.6B
- Portfolio turnover (prospectus): 225%
- Securities lending: none during the year
CTRZX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley | $9.9B | 21.10% |
| JPMorgan | $7.2B | 15.21% |
| Citi | $7.1B | 15.01% |
| Goldman Sachs | $7.0B | 14.79% |
| Barclays | $3.8B | 8.11% |
| Wells Fargo | $3.5B | 7.50% |
| Mizuho | $2.4B | 5.17% |
| Citadel Securities LLC | $2.3B | 4.93% |
| Deutsche Bank | $2.2B | 4.71% |
| Nomura Securities International Inc. | $1.6B | 3.47% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.